|
|
Is there any relationship between the exposure to mycophenolic acid and the clinical status in children with lupus?
C. Jurado
,
Brigitte Bader-Meunier
,
Bruno Ranchin
,
Stéphane Decramer
,
Michel Fischbac
et al.
Pediatric Rheumatology, 2011, 9 (Suppl 1), pp.P248
Journal articles
inserm-00624790v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Large scale analysis of routine dose adjustments of mycophenolate mofetil based on global exposure in renal transplant patients.
Franck Saint-Marcoux
,
Sophie Vandierdonck
,
Aurélie Prémaud
,
Jean Debord
,
Annick Rousseau
et al.
Journal articles
inserm-00590457v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
The influence of pharmacogenetics and cofactors on clinical outcomes in kidney transplantation.
Nicolas Picard
,
Pierre Marquet
Journal articles
inserm-00577136v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
CYP3A5 genotype does not influence everolimus in vitro metabolism and clinical pharmacokinetics in renal transplant recipients.
Nicolas Picard
,
Koukeb Rouguieg-Malki
,
Nassim Kamar
,
Lionel Rostaing
,
Pierre Marquet
et al.
Journal articles
inserm-00542366v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Population pharmacokinetics of mycophenolic acid in pediatric renal transplant patients using parametric and nonparametric approaches.
Aurélie Prémaud
,
Lt Weber
,
B. Tönshoff
,
V. W Armstrong
,
M. Oellerich
et al.
Journal articles
inserm-00541907v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Population pharmacokinetic model and Bayesian estimator for two tacrolimus formulations - twice daily Prograf(®) and once daily Advagraf(®).
Jean-Baptiste Woillard
,
Brenda C.M. de Winter
,
Nassim Kamar
,
Pierre Marquet
,
Lionel Rostaing
et al.
Journal articles
inserm-00544205v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|